Neuroligin 1—A New Substrate for γ-Secretase
Webinar.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=3296 Alzheimer's Disease α-Secretase
373 RESULTS
You searched Esther AND Landhuis
Sort By:
Webinar.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=3296 Alzheimer's Disease α-Secretase
progranulin deficiency modifies disease in animal models of Parkinson’s, AD or ALS.—Esther Landhuis None
said.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=3286 Parkinson's Disease LRRK2
in 2002 with Kwang Meng Seng, a physician and venture capitalist.—Esther Landhuis. Q&A With Claude
controls, suggesting it could serve as a disease biomarker, Abeliovich said.—Esther Landhuis None
in Phase 2 but failed to show clinical efficacy in a Phase 3 AD trial (see ARF related news story).—Esther
wrote.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=3269 Parkinson's Disease Research
might not be fully effective against late-onset AD.”—Esther Landhuis None
a clinical-grade assay.”—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=3259 Alzheimer's
CSF flux and see if that slows plaque buildup.—Esther Landhuis None
hypothesis,” Chapuis suggested in an e-mail to Alzforum.—Esther Landhuis. None
to treat lipodystrophy in HIV patients, Baker said.—Esther Landhuis None
and assessing effects of therapy would be easier and quicker?” he wrote to Alzforum.—Esther Landhuis. None
forward with these compounds in clinical trials.”—Esther Landhuis. None
going to give us new handles on investigating the neuropathology of diseases like AD.”—Esther Landhuis